<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02133378</url>
  </required_header>
  <id_info>
    <org_study_id>2014-01</org_study_id>
    <nct_id>NCT02133378</nct_id>
  </id_info>
  <brief_title>Prospective Clinical Trial of the Hemopatch Topic Hemostatic in Cardiac Surgery</brief_title>
  <official_title>Prospective, Randomized Clinical Trial of the Hemopatch Topic Hemostatic in Cardiac Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiochirurgia E.H.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cardiochirurgia E.H.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A new topical hemostatic agent composed of a specifically-formulated porous collagen matrix,
      coated on one side with a thin protein bonding layer (known as NHS-PEG) has been reported to
      be extremely effective, in addition to traditional means, in terminating bleeding during
      cardiac operations with control rates as high as 97,5%. The investigators compared such
      hemostatic agent (Hemopatch; Baxter Inc, Deerfield, IL) with traditional optimized hemostasis
      routine.

      Following sample size calculation, in a prospective randomized study design, 100 patients
      will be treated with Hemopatch and 100 patients will receive traditional optimized hemostasis
      routine (comparison group).

      To make the two cohorts as comparable as possible enrollment will be restricted to moderately
      bleeding vascular anastomosis of Dacron grafts to ascending aorta or moderately bleeding
      transversal aortotomy.

      Study endpoints are the following: rate of successful intraoperative hemostasis (identified
      by cessation of bleeding in less than 3 minutes from application) and time required for
      hemostasis; overall postoperative bleeding; rate of transfusion of blood products; rate of
      surgical revision for bleeding; postoperative morbidity; and intensive care unit stay.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Successful Hemostasis in under 3 minutes</measure>
    <time_frame>3 minutes</time_frame>
    <description>Application of Hemopatch or traditional techniques (compression with dry or wet gauze or similar) are considered successful if hemostasis is reached in under 3 minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post Operative Blood Loss</measure>
    <time_frame>6 hours</time_frame>
    <description>Blood loss in the first 7 hours postoperatively</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Allogeneic Blood Transfusion</measure>
    <time_frame>4 days</time_frame>
    <description>Allogeneic Blood Transfusion in the first 4 days after surgery</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">170</enrollment>
  <condition>Bleeding</condition>
  <arm_group>
    <arm_group_label>Hemopatch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of Hemopatch on bleeding spot</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Traditional techniques hemostasis (dry or wet gauze compression or similar)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hemopatch</intervention_name>
    <description>Baxter Hemopatch</description>
    <arm_group_label>Hemopatch</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Traditional Hemostasis Techniques (dry or wet gauze compression or similar)</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Surgery on Ascending Aorta with Dacron Graft or transverse Aortotomy

          -  Moderate bleeding

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>European Hospital</name>
      <address>
        <city>Rome</city>
        <zip>00151</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Nasso G, Piancone F, Bonifazi R, Romano V, Visicchio G, De Filippo CM, Impiombato B, Fiore F, Bartolomucci F, Alessandrini F, Speziale G. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg. 2009 Nov;88(5):1520-6. doi: 10.1016/j.athoracsur.2009.07.014.</citation>
    <PMID>19853105</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2014</study_first_submitted>
  <study_first_submitted_qc>May 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2014</study_first_posted>
  <last_update_submitted>September 13, 2017</last_update_submitted>
  <last_update_submitted_qc>September 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cardiochirurgia E.H.</investigator_affiliation>
    <investigator_full_name>Luca Weltert</investigator_full_name>
    <investigator_title>Dr. Luca Weltert</investigator_title>
  </responsible_party>
  <keyword>Bleeding</keyword>
  <keyword>Hemostatic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

